British Columbia Cancer Agency Branch;THE UNIVERSITY OF BRITISH COLUMBIA
发明人:
申请号：
EP17177010.0
公开号：
EP3252032A1
申请日:
2009.07.02
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
This invention provides compound having a structure of Formula I or Formula II. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.
